About the journal
Trends in cancer is a journal published by Elsevier BV in United States. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 6,830 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier BV
- ISSN
- 2405-8033 · 2405-8025
- Country
- United States
- Access
- Not open access / not declared
- Declared publication charge
- 6,830 USD
- Declared peer-review model
- peer_review
- Official website
- https://www.sciencedirect.com/journal/trends-in-cancer
Index listings
- MEDLINE · 2017-01-01
- PUBMED · 2015-09-01
- Indexing
- MEDLINE · PUBMED
- APC
- 6,830 USD
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 86 days received→accepted — computed from PubMed (n=100)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
1397
Last recorded publication year
2026
h-index
137
i10-index
799
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 82%
- ORCID iDs in current deposits
- 66%
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101665956
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cancer Immunotherapy and Biomarkers
- Diverse Scientific and Economic Studies
- Diverse Scientific and Economic Studies
- Cancer Cells and Metastasis
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Cancer Immunotherapy and Biomarkers
Show all subjects (75)
- Cancer Immunotherapy and Biomarkers
- Immunotherapy and Immune Responses
- Legal Cases and Commentary
- Legal Cases and Commentary
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- CAR-T cell therapy research
- CAR-T cell therapy research
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Immune cells in cancer
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Legal case studies and regulations
- Legal case studies and regulations
- T-cell and B-cell Immunology
- Immune cells in cancer
- Chromatin Remodeling and Cancer
- Cancer-related Molecular Pathways
- Human auditory perception and evaluation
- Human auditory perception and evaluation
- Epigenetics and DNA Methylation
- Glioma Diagnosis and Treatment
- Pancreatic and Hepatic Oncology Research
- RNA modifications and cancer
- Pancreatic and Hepatic Oncology Research
- RNA modifications and cancer
- Pharmacy and Medical Practices
- Pharmacy and Medical Practices
- Single-cell and spatial transcriptomics
- Single-cell and spatial transcriptomics
- DNA Repair Mechanisms
- Glioma Diagnosis and Treatment
- Cancer Research and Treatments
- DNA Repair Mechanisms
- Cancer-related Molecular Pathways
- Cell death mechanisms and regulation
- Glioma Diagnosis and Treatment
- Cancer-related Molecular Pathways
- Pancreatic and Hepatic Oncology Research
- Cellular Mechanics and Interactions
- Cancer Research and Treatments
- Genetic factors in colorectal cancer
- CRISPR and Genetic Engineering
- CRISPR and Genetic Engineering
- Cancer, Lipids, and Metabolism
- Genomics and Chromatin Dynamics
- Lung Cancer Treatments and Mutations
- DNA Repair Mechanisms
- Genetic factors in colorectal cancer
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- RNA Research and Splicing
- CAR-T cell therapy research
- RNA Research and Splicing
- Cancer-related molecular mechanisms research
- Mathematical Biology Tumor Growth
- Metabolism, Diabetes, and Cancer
- Acute Myeloid Leukemia Research
- PI3K/AKT/mTOR signaling in cancer
- TGF-β signaling in diseases
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ